14 results
8-K/A
EX-99.1
HBIO
Harvard Bioscience Inc.
18 Mar 19
Harvard Bioscience Reports Strong Fourth Quarter and Year-End 2018 Results, and Issues 2019 Financial Guidance
5:10pm
for innovation with product launches in telemetry, electrophysiology, and electroporation, expanding our applications in key life science research markets
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
28 Feb 19
Harvard Bioscience Reports Strong Fourth Quarter and Year-End 2018 Results, and Issues 2019 Financial Guidance
4:10pm
of DSI and sale of Denville Scientific. It was also a great year for innovation with product launches in telemetry, electrophysiology, and electroporation
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
6 Nov 13
Harvard Bioscience Becomes Pure-Play Developer, Manufacturer and Marketer of Tools for Life Science Research
12:00am
. With our initiatives unified in this way, we expect to continue the tradition of excellence and innovation which is our legacy."
In commenting
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
16 Oct 13
Departure of Directors or Certain Officers
12:00am
Officer and for making this a seamless transition."
Robert Gagnon stated, "I have witnessed the need for ever-greater innovation in the life science
8-K
EX-99.1
87ydhl
8 Mar 05
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
gmogjr6agen5434s
25 Nov 03
Harvard Bioscience Acquires Selected Assets of Hoefer 1-D Electrophoresis Business from Amersham Biosciences
12:00am
8-K
EX-99.1
2s87n98q34m4t m1l
1 May 03
Financial statements and exhibits
12:00am
425
bxnvnk4y
23 Jul 02
Business combination disclosure
12:00am
425
k97 h7hhjsm1vfa233sn
18 Jul 02
Business combination disclosure
12:00am
- Prev
- 1
- Next